In a new trial, patients with follicular lymphoma had a significantly higher response to treatment and a nearly 80% reduction ...

The decision to use newer agents in relapsed/refractory follicular lymphoma is heavily influenced by the disease’s inherent ...

The treatment of relapsed or refractory follicular lymphoma (RRFL) is distinct from patients who are receiving treatment for the first time, due to differences in the nature of the disease. Relapsed ...

Treatment with Brukinsa and Gazyva poses a new option for certain patients with follicular lymphoma, with tolerable side effects, an expert told CURE®. Certain patients with relapsed or refractory ...

The introduction of chemoimmunotherapy in the treatment of follicular lymphoma resulted in clinically and statistically significant improvements in patient outcomes. Women are more likely to receive ...

Follicular lymphoma treatment options are changing, and according to one expert, immunotherapy could become a major part of therapy sequencing. When it comes to treating follicular lymphoma, future ...

Radiation therapy or chemotherapy plus a monoclonal antibody drug such as rituximab (Rituxan) may treat and even cure follicular lymphoma if it's diagnosed very early.. But most people are diagnosed ...

Although there is increasing knowledge about the pathobiology of follicular lymphoma (FL), the incorporation of new agents is challenged by the long clinical course and inherent heterogeneity of the ...

There are two types of lymphomas: Hodgkin's and non-Hodgkin's, based on the kind of white blood cell they affect. Follicular lymphoma is a non-Hodgkin's lymphoma that affects white blood cells called ...